コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lly "unresectable" for cure and treated with palliative therapy.
2 There is no treatment for EB, only palliative therapy.
3 have made a positive impact on curative and palliative therapy.
4 rrence and no survival benefit compared with palliative therapy.
5 e is currently no effective treatment except palliative therapy.
6 sfunction, reirradiation largely serves as a palliative therapy.
7 ncer (28% reduction), 14 fewer men receiving palliative therapy (35% reduction), and a total of 73 li
8 ophylaxis late in the course of curative and palliative therapy (80% v 53%); and (3) treatment of afe
9 rostate carcinoma who received 89Sr-chloride palliative therapy and from 10 age-matched healthy volun
10 andomized trials of first-line, salvage, and palliative therapy and the role of surgery after chemoth
11 onally practiced involves the institution of palliative therapy as the disease progresses at a time w
13 s were treated with multimodality therapy or palliative therapy because of contraindications for tran
15 ons confer survival advantages compared with palliative therapies for hepatocellular carcinoma (HCC),
17 he decision was likely preference-sensitive (palliative therapy for metastatic cancer), and treatment
19 nhibitor (MKI) sorafenib can be an effective palliative therapy for patients with hepatocellular carc
21 sarterial chemoembolization and sorafenib as palliative therapy have improved the outlook for HCC pat
23 asis for atrial fibrillation is unknown, and palliative therapy is used to control the ventricular ra
25 of brain metastases was considered a form of palliative therapy only, but more recently it has been s
26 treatments, most patients currently receive palliative therapies with steroid molecules such as pred
27 ssociated with cost-effectiveness studies of palliative therapy, with emphasis on the problem of calc
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。